{"disease":{"id":"diabetic-kidney-disease-dkd","name":"diabetic kidney disease dkd"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07032116","title":"YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":4472,"lead_sponsor_name":"Liu Hongfang","has_results":false},{"nct_id":"NCT07348718","title":"Rubix LS Diabetic Kidney Disease (DKD) Registry Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Rubix LS","has_results":false},{"nct_id":"NCT07271186","title":"Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":270,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT07034807","title":"YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study2","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":228,"lead_sponsor_name":"Liu Hongfang","has_results":false},{"nct_id":"NCT06962098","title":"Efficacy and Safety Study of Isuzinaxib in Subjects With DKD","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":186,"lead_sponsor_name":"Aptabio Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04689074","title":"Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari","has_results":false},{"nct_id":"NCT07326631","title":"Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"College of Physicians and Surgeons Pakistan","has_results":false},{"nct_id":"NCT06639529","title":"Preliminary Study of CXCL3 As a Biomarker of Diabetic Kidney Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"The First Hospital of Jilin University","has_results":false},{"nct_id":"NCT06969807","title":"Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT04419467","title":"Vascular Endothelial Growth Factor-B (VEGF-B) Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":114,"lead_sponsor_name":"CSL Behring","has_results":true},{"nct_id":"NCT07177898","title":"ALLOPURINOL AND LISINOPRIL FOR DIABETIC KIDNEY PROTECTION: A COMPARATIVE STUDY IN NORMOURICEMIC TYPE 2 DIABETICS","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Narowal Medical College","has_results":false},{"nct_id":"NCT06866158","title":"Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney Disease","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":80,"lead_sponsor_name":"PT. JES Kasih Nusantara Sejahterah","has_results":false},{"nct_id":"NCT07240987","title":"Mesenchymal Stem Cells for Chronic Kidney Diseases","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":32,"lead_sponsor_name":"The First Affiliated Hospital of Air Force Medicial University","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}